| A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese Subjects (NCT06044233) | Zhejiang ACEA Pharmaceutical Co. Ltd. | 2023-09-28 |
| Relative Bioavailability of Two Lutikizumab Formulations and Pharmacokinetics, Safety, and Tolerability of Lutikizumab in Chinese Participants (NCT06067568) | AbbVie | 2023-09-28 |
| Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT05920798) | Mayo Clinic | 2023-09-28 |
| Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness (NCT05691491) | National Cancer Institute (NCI) | 2023-09-28 |
| A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III (NCT06097390) | Novo Nordisk A/S | 2023-09-28 |
| A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome (NCT05979831) | Daiichi Sankyo | 2023-09-28 |
| A Study of Single and Multiple Oral Doses of TollB-001 (NCT06103773) | Toll Biotech Co. Ltd. (Beijing) | 2023-09-28 |
| Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors (NCT06088004) | Suzhou Abogen Biosciences Co., Ltd. | 2023-09-28 |
| Siplizumab for Sickle Cell Disease Transplant (NCT06078696) | Columbia University | 2023-09-28 |
| First-In-Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Escalating Single And Multiple Doses Of CSL040 In Healthy Subjects (NCT05937581) | CSL Behring | 2023-09-28 |
| A Clinical Study of Intraperitoneal T3011 Given as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal Cancer (NCT06200376) | West China Hospital | 2023-09-28 |
| Understanding Rebound Pain After Regional Anesthesia Resolution in Healthy Volunteers (NCT06005480) | Brigham and Women's Hospital | 2023-09-28 |
| Study of GS-0272 in Participants With Rheumatoid Arthritis (NCT06031415) | Gilead Sciences | 2023-09-28 |
| Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT05961839) | Schrödinger, Inc. | 2023-09-27 |
| CDI-988 Safety Study in Healthy Participants (NCT05977140) | Cocrystal Pharma, Inc. | 2023-09-27 |
| An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors (NCT06076291) | Hangzhou Sumgen Biotech Co., Ltd. | 2023-09-27 |
| Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects (NCT06063330) | Red Queen Therapeutics, Inc. | 2023-09-27 |
| Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors (NCT05636618) | Perspective Therapeutics | 2023-09-27 |
| QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (NCT06056752) | Anhui Provincial Hospital | 2023-09-27 |
| A Study of TAK-279 in Adults With or Without Kidney Problems (NCT05992155) | Takeda | 2023-09-27 |
| 9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer (NCT06079112) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2023-09-27 |
| First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations (NCT06043817) | Pierre Fabre Medicament | 2023-09-26 |
| Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy (NCT06070051) | Virion Therapeutics | 2023-09-26 |
| FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition (NCT05937295) | University Hospital Tuebingen | 2023-09-26 |
| Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Severe Kidney Disease (NCT06160622) | Guangdong Raynovent Biotech Co., Ltd | 2023-09-26 |
| A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria (NCT06138327) | BioMarin Pharmaceutical | 2023-09-26 |
| Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia (NCT06276361) | Rovi Pharmaceuticals Laboratories | 2023-09-26 |
| The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS207 in Patients With Advanced Malignant Tumor (NCT06022250) | Shanghai Junshi Bioscience Co., Ltd. | 2023-09-26 |
| A Study of ADRX-0706 in Select Advanced Solid Tumors (NCT06036121) | Adcentrx Therapeutics | 2023-09-26 |
| Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC) (NCT06006299) | University of Alabama at Birmingham | 2023-09-26 |
| A Study of ES009 in Subjects With Locally Advanced or Metastatic Solid Tumors (NCT06007482) | Elpiscience Biopharma Australia Pty. Ltd. | 2023-09-26 |
| A Study to Evaluate Laser Speckle Contrast Imaging to Assess Changes in Chemical Agent-Induced Skin Blood Flow in Healthy Participants (MK-0000-420) (NCT06809569) | Merck Sharp & Dohme LLC | 2023-09-25 |
| Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies (NCT05609942) | Blueprint Medicines Corporation | 2023-09-25 |
| Positron Emission Tomography (PET) Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease (NCT06053424) | AstraZeneca | 2023-09-25 |
| A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms (NCT05936359) | Incyte Corporation | 2023-09-25 |
| Drug-drug Interaction Study Between UIC202304, and UIC202305 (NCT07735052) | Korea United Pharm. Inc. | 2023-09-25 |
| A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants (NCT06060977) | Inmagene LLC | 2023-09-25 |
| A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma (NCT06049030) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2023-09-25 |
| Phase I/II Study of Linperlisib Plus Chidamide for R/R Peripheral T-cell Lymphoma: a Prospective, Multi-center Study (NCT06083701) | Peking Union Medical College Hospital | 2023-09-25 |
| A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® Relative to INBRIJA® (NCT06037590) | PureIMS B.V. | 2023-09-25 |
| Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1) (NCT05907213) | Grace Lim, MD, MS | 2023-09-25 |
| Fisetin to Improve Vascular Function in Older Adults (NCT06133634) | University of Colorado, Boulder | 2023-09-25 |
| Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer (NCT05673200) | National Cancer Institute (NCI) | 2023-09-25 |
| Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI (NCT05845749) | University of California, San Francisco | 2023-09-25 |
| Effect of Addition of Dexmedetomidine or Ketamine to Intravenous Infusion of Lidocaine on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries. (NCT06631625) | Alexandria University | 2023-09-24 |
| A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC) (NCT05975047) | Liveome Inc. | 2023-09-24 |
| FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach (NCT06071312) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2023-09-23 |
| A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers (NCT06013163) | Empros Pharma AB | 2023-09-22 |
| A Study YL201 in Patients With Selected Advanced Solid Tumors (NCT06057922) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2023-09-22 |
| Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets (NCT06214130) | Desitin Arzneimittel GmbH | 2023-09-22 |
| Clostridioides Difficile Colonisation (NCT05693077) | Leiden University Medical Center | 2023-09-22 |
| The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure (NCT05989958) | Hexaell Biotech Co., Ltd. | 2023-09-22 |
| A Phase 1 Study of VG-3927 in Healthy Adults and Patients With Alzheimer's Disease (NCT06343636) | Vigil Neuroscience, Inc. | 2023-09-22 |
| A Study of TAK-279 in Adults With or Without Liver Damage (NCT05976321) | Takeda | 2023-09-22 |
| A Study to Evaluate the Effect of Food on the Drug Levels of BMS-986196 in Healthy Adult Participants (NCT06034899) | Bristol-Myers Squibb | 2023-09-22 |
| Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration. (NCT05980091) | ART Fertility Clinics LLC | 2023-09-22 |
| Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects (NCT06043739) | Lakefront Biotherapeutics NV | 2023-09-22 |
| Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons (NCT05683834) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-09-22 |
| RY_SW01 Cell Injection Therapy in Systemic Sclerosis (NCT06058091) | Jiangsu Renocell Biotech Company | 2023-09-22 |
| Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD). (NCT06051448) | Children's Hospital of Philadelphia | 2023-09-22 |
| A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer. (NCT05938270) | AstraZeneca | 2023-09-21 |
| A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets (NCT06024915) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-09-21 |
| A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus (NCT06013995) | Bristol-Myers Squibb | 2023-09-21 |
| A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines (NCT05988203) | BioNTech SE | 2023-09-21 |
| Oral Dronabinol-HIV (NCT06034314) | Yale University | 2023-09-21 |
| Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients (NCT06427291) | Fudan University | 2023-09-21 |
| A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors (NCT05981703) | BeOne Medicines | 2023-09-21 |
| PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor (NCT05801237) | Shanghai HyaMab Biotech Co.,Ltd. | 2023-09-21 |
| Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia (NCT05863234) | Hiroshima University Hospital | 2023-09-21 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A (NCT05987449) | Hoffmann-La Roche | 2023-09-21 |
| A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities (NCT06023095) | Eli Lilly and Company | 2023-09-21 |
| A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer (NCT06200363) | West China Hospital | 2023-09-21 |
| A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma (NCT06018129) | Genmab | 2023-09-21 |
| A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) (NCT06052306) | Bayer | 2023-09-20 |
| Tailoring OT and RD Services for Home-delivered Meal Clients (NCT06059404) | Ohio State University | 2023-09-20 |
| Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With Carotid Atherosclerotic Plaques (NCT03382249) | First Affiliated Hospital of Harbin Medical University | 2023-09-20 |
| Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial (NCT06063057) | Sinovac Biotech Co., Ltd | 2023-09-20 |
| A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005) (NCT06665230) | Merck Sharp & Dohme LLC | 2023-09-20 |
| Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body (NCT06066112) | The Affiliated Hospital of Qingdao University | 2023-09-20 |
| A Study to Evaluate the Effect of Food, Formulation, and a Proton Pump Inhibitor (PPI) on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-003) (NCT06619314) | Merck Sharp & Dohme LLC | 2023-09-20 |
| A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants (NCT06052462) | Eli Lilly and Company | 2023-09-20 |
| High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM (NCT06045286) | Jiangsu Cancer Institute & Hospital | 2023-09-20 |
| A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer. (NCT05917470) | Oncternal Therapeutics, Inc | 2023-09-20 |
| Dexmedetomidine Versus Ketamine Versus Magnesium Sulfate for the Prevention of Emergence Agitation Following Sevoflurane Induced Anesthesia in Cardiac Catheterization in Pediatrics (NCT06077539) | Cairo University | 2023-09-20 |
| Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19) (NCT06022757) | Evopoint Biosciences Inc. | 2023-09-20 |
| Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT) (NCT06621043) | Fenix Innovation Group | 2023-09-20 |
| the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction (NCT06060691) | Deraya University | 2023-09-20 |
| WMT for Autism Spectrum Disorder (ASD) (NCT06030752) | The Second Hospital of Nanjing Medical University | 2023-09-20 |
| Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction (NCT06514378) | Instituto De Investigación Sanitaria Puerta De Hierro-Segovia De Arana | 2023-09-19 |
| Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) (NCT06094101) | University Hospital Tuebingen | 2023-09-19 |
| A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors (NCT05957536) | D3 Bio (Wuxi) Co., Ltd | 2023-09-19 |
| A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC (NCT05773105) | Sun Yat-sen University | 2023-09-19 |
| A Study to Investigate the Effects of Acid Reducing Agents on Pharmacokinetics of PC14586 in Healthy Participants (NCT06054464) | PMV Pharmaceuticals, Inc | 2023-09-19 |
| To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV (NCT05854381) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-09-19 |
| A Study Assessing the Safety of Oral ATH-399A in Healthy Adult Participants (NCT06088784) | HanAll BioPharma Co., Ltd. | 2023-09-19 |
| A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors (NCT05989724) | Qurgen Inc. | 2023-09-19 |
| The Pharmacokinetic and Bioavailability of GenSci094 Before and After a Change in Manufacturing Site (NCT06095206) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2023-09-19 |
| A Bridging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB06-036 in Healthy Subjects in China (NCT06101316) | Shanghai Zhimeng Biopharma, Inc. | 2023-09-19 |
| Mass Balance Study of [14C]RAY1216 in Healthy Adult Male Subjects in China (NCT06362460) | Guangdong Raynovent Biotech Co., Ltd | 2023-09-18 |
| Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO (NCT05699005) | University Hospital, Lille | 2023-09-18 |